Literature DB >> 11179272

Cytomegalovirus, Chlamydia pneumoniae, and Helicobacter pylori IgG antibodies and restenosis after stent implantation: an angiographic and intravascular ultrasound study.

F Schiele1, M K Batur, M F Seronde, N Meneveau, P Sewoke, A Bassignot, G Couetdic, F Caulfield, J P Bassand.   

Abstract

OBJECTIVE: To determine the impact of previous infection with cytomegalovirus, Chlamydia pneumoniae, and Helicobacter pylori on neointimal proliferation after coronary angioplasty with stent implantation.
DESIGN: The study population was made up of 180 patients who had stent implantation in a native coronary artery with systematic angiographic and intravascular ultrasound (IVUS) follow up at six months. Quantitative coronary angiography was used to assess the late lumen loss. The mean area of neointimal tissue within the stent and the ratio of neointimal tissue to stent area were assessed from IVUS images. Previous cytomegalovirus, C pneumoniae, and H pylori infection was identified by IgG antibody determination.
RESULTS: Previous cytomegalovirus infection was detected in 50% of the population, previous C pneumoniae in 18%, and previous H pylori in 33%. Mean (SD) reference diameter was 2.94 (0.48) mm and mean minimum lumen diameter after stent implantation was 2.45 (0.42) mm. At six months, the mean late loss was 0.74 (0.50) mm, the mean neointimal tissue area was 3.8 (1.7) mm(2), and the average ratio of neointimal tissue area to stent area was 45 (18)%. None of these variables of restenosis was linked to any of the three infectious agents. By multivariate analysis, lesion length was the variable best correlated with mean neointimal tissue area, the ratio of neointimal tissue to stent area, and late loss, explaining respectively 31%, 39%, and 8% of their variability.
CONCLUSIONS: Previous infection with cytomegalovirus, C pneumoniae, or H pylori was not a contributing factor in the process of restenosis after stent implantation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179272      PMCID: PMC1729637          DOI: 10.1136/heart.85.3.304

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  25 in total

Review 1.  Chronic infections and coronary heart disease: is there a link?

Authors:  J Danesh; R Collins; R Peto
Journal:  Lancet       Date:  1997-08-09       Impact factor: 79.321

2.  Intimal hyperplasia thickness at follow-up is independent of stent size: a serial intravascular ultrasound study.

Authors:  R Hoffmann; G S Mintz; A D Pichard; K M Kent; L F Satler; M B Leon
Journal:  Am J Cardiol       Date:  1998-11-15       Impact factor: 2.778

3.  Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty.

Authors:  J Carlsson; S Miketic; K H Mueller; J Brom; R Ross; R von Essen; U Tebbe
Journal:  Lancet       Date:  1997-10-25       Impact factor: 79.321

4.  Is there MUSIC in IVUS guided stenting? Is this MUSIC going to be a MUST? Multicenter Ultrasound Stenting in Coronaries Study.

Authors:  P W Serruys; N V Deshpande
Journal:  Eur Heart J       Date:  1998-08       Impact factor: 29.983

5.  Validation of the in vivo intravascular ultrasound measurement of in-stent neointimal hyperplasia volumes.

Authors:  R Mehran; G S Mintz; M K Hong; F O Tio; O Bramwell; A Brahimi; K M Kent; A D Pichard; L F Satler; J J Popma; M B Leon
Journal:  J Am Coll Cardiol       Date:  1998-09       Impact factor: 24.094

6.  High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis.

Authors:  A Blum; M Giladi; M Weinberg; G Kaplan; H Pasternack; S Laniado; H Miller
Journal:  Am J Cardiol       Date:  1998-04-01       Impact factor: 2.778

Review 7.  Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research.

Authors:  P Libby; D Egan; S Skarlatos
Journal:  Circulation       Date:  1997-12-02       Impact factor: 29.690

8.  Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy.

Authors:  T Kimura; S Kaburagi; T Tamura; H Yokoi; Y Nakagawa; H Yokoi; N Hamasaki; H Nosaka; M Nobuyoshi; G S Mintz; J J Popma; M B Leon
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

9.  Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis.

Authors:  M Davidson; C C Kuo; J P Middaugh; L A Campbell; S P Wang; W P Newman; J C Finley; J T Grayston
Journal:  Circulation       Date:  1998-08-18       Impact factor: 29.690

10.  Predictive factors of restenosis after coronary stent placement.

Authors:  A Kastrati; A Schömig; S Elezi; H Schühlen; J Dirschinger; M Hadamitzky; A Wehinger; J Hausleiter; H Walter; F J Neumann
Journal:  J Am Coll Cardiol       Date:  1997-11-15       Impact factor: 24.094

View more
  5 in total

Review 1.  Association between Bacterial Infection and Peripheral Vascular Disease: A Review.

Authors:  Jacek Budzyński; Joanna Wiśniewska; Marek Ciecierski; Anna Kędzia
Journal:  Int J Angiol       Date:  2015-03-23

Review 2.  Role of Helicobacter pylori infection in pathogenesis of atherosclerosis.

Authors:  Rajesh Vijayvergiya; Ramalingam Vadivelu
Journal:  World J Cardiol       Date:  2015-03-26

3.  Influence of intimal Chlamydophila pneumoniae persistence on cardiovascular complications after coronary intervention.

Authors:  I Tuleta; D Reek; P Braun; G Bauriedel; G Nickenig; D Skowasch; R Andrié
Journal:  Infection       Date:  2014-10-26       Impact factor: 3.553

Review 4.  Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence.

Authors:  Jacek Budzyński; Marek Koziński; Maria Kłopocka; Julia Maria Kubica; Jacek Kubica
Journal:  Clin Res Cardiol       Date:  2014-05-10       Impact factor: 5.460

Review 5.  Association of Helicobacter pylori infection with coronary artery disease: is it an independent risk factor?

Authors:  Mohamed Riad
Journal:  Egypt Heart J       Date:  2021-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.